Preclinical evidence for the use of anti-Trop-2 antibody-drug conjugate Sacituzumab govitecan in cerebral metastasized castration-resistant prostate cancer
抗Trop-2抗体-药物偶联物Sacituzumab govitecan在脑转移性去势抵抗性前列腺癌中的应用临床前证据
期刊:Cancer Medicine
影响因子:2.9
doi:10.1002/cam4.7320
Richard Weiten, Max Niemann, Eduard Below, Lea L Friker, Damian J Ralser, Marieta Toma, Glen Kristiansen, Oliver Hahn, Sabrina Zechel, Viktor Grünwald, Tobias Bald, Johannes Siewert, Torsten Pietsch, Manuel Ritter, Michael Hölzel, Markus Eckstein, Abdullah Alajati, Philipp Krausewitz, Niklas Klümper
肿瘤
前列腺癌
FCM
IF
IHC
MICS
Human
TACD2
